Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

JAN

JanOne (JAN)

JanOne Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:JAN
일자시간출처헤드라인심볼기업
2024/05/1705:00PR Newswire (US)JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain FintechNASDAQ:JANJanOne Inc
2024/05/1320:30PR Newswire (US)JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology ProviderNASDAQ:JANJanOne Inc
2024/05/1105:10PR Newswire (US)JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology ProviderNASDAQ:JANJanOne Inc
2024/05/0705:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2024/05/0705:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
2024/03/1522:00PR Newswire (US)JanOne Regains Compliance with Nasdaq's Listing RequirementsNASDAQ:JANJanOne Inc
2024/02/2906:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2024/02/1002:36Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
2024/02/0906:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2024/01/1306:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/10/1205:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/09/2306:00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
2023/09/2200:30PR Newswire (US)JanOne to Present at the Dawson James 8th Annual Investment ConferenceNASDAQ:JANJanOne Inc
2023/09/2122:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:JANJanOne Inc
2023/09/1605:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/09/0102:30PR Newswire (US)JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment ConferenceNASDAQ:JANJanOne Inc
2023/08/3002:30PR Newswire (US)JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic PainNASDAQ:JANJanOne Inc
2023/08/2906:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JANJanOne Inc
2023/08/2603:30PR Newswire (US)JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
2023/08/2505:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:JANJanOne Inc
2023/08/2405:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/08/2306:30PR Newswire (US)JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
2023/08/2301:54Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
2023/08/1908:00PR Newswire (US)JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
2023/08/1901:42PR Newswire (US)JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
2023/08/1704:55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JANJanOne Inc
2023/08/1605:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JANJanOne Inc
2023/07/0805:19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
2023/07/0105:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
2023/06/2821:30PR Newswire (US)JanOne files international patent application for methods of using low dose naltrexone to treat chronic painNASDAQ:JANJanOne Inc
 검색 관련기사 보기:NASDAQ:JAN